Search results for: 'part pet analysis for laboratory develop'

23 Aug 2024  |  Global  |  Market Research

Growth Opportunities in the Pet Food Ingredients Sector, Global, 2024 2030

The Growing Demand for Personalized Pet Food and Supplement Products due to Pet Humanization Trend Drives Transformational Growth

Infographics

×

The pet food ingredient industry is experiencing significant changes, the most important of which are the humanization of pets and technological advancement. This Frost & Sullivan analysis examines the pet food ingredient industry by segment: ingredient types, applications, and geographic regions. Ingredient types include probiotics, prebiotics, vi...

Qualified respondents to this Frost & Sullivan survey were invited to participate in a telephone interview examining their laboratory s product purchasing process in 2023 and expectations for 2024. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. The survey provides companies with actionable and trendin...

This Frost Radar for the laboratory information management systems (LIMS) industry benchmarks providers offering workflow management and paperless tracking capabilities to help improve process efficiencies for life sciences companies. LIMS have several functionalities, such as obtaining, storing, managing, retrieving, and recording laboratory data...

With persistent geopolitical tensions and the resultant trade fragmentation continuing to shape the global economy, policy priorities among countries advanced and emerging are shifting toward macroeconomic frameworks that will insulate them from external shocks. Incremental reforms that support sustainability and Industry 5.0 practices will have pr...

Immuno-oncology (I-O) therapies target tumors by harnessing the host s immune system. With the growing incidence and prevalence of various types of aggressive and refractory cancers, the next-generation I-O therapy pipeline has witnessed significant growth. Chimeric antigen receptor (CAR)-T cell therapy and tumor-targeted antibody therapies, includ...

This study examines major automotive aftermarket parts distributors and retailers in North America (the United States and Canada) between 2019 and 2023. The research highlights the trends, impact of technological evolution, shifting market dynamics, and product and customer engagement. By profiling key distributors and retailers, this study exp...

Electronic devices are an integral part of human life, serving a multitude of functionalities. Many application areas for example, electronic gadgets, health monitoring and medical devices, activity tracking, smart cards, and wearable electronics require lightweight, flexible, and compact energy storage solutions. The focus on miniaturization and c...

By 2023, biologics constituted 44% of the therapeutic pipeline, with antibodies and recombinant proteins as leading categories. Nevertheless, advancements in these fields decelerated, with most of the expansion happening in heterologous cell treatments, synthetic nucleic acids, and viruses. The global biologics pipeline will shift toward more compl...

The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity. Overall R&D expenditure totals about $276....